DELAYED CEREBRAL ISCHEMIA FOLLOWING AN ANEURYSMAL SUBARACHNOID HEMORRHAGE: THE SWORD OF DAMOCLES
DOI:
https://doi.org/10.67214/g376zp93Downloads
References
1. Dodd WS, Laurent D, Dumont AS, Hasan DM, Jabbour PM, Starke RM, Hosaka K, Polifka AJ, Hoh BL, Chalouhi N. Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. Journal of American Heart Association 2021;10:e021845.
2. Flynnn L, Andrews P. Advances in the understanding of delayed cerebral ishaemia after aneurysmal subarachnoid haemorrhage. F1000Res. 2015;4:1200.
3. Stienen MN, Germans M, Burkhardt J-K, Neidert MC, Fung C, Bervini D, Zumofen D, Roethlisberger M, Marbacher S, Maduri R, et al. Predictors of in-hospital death after aneurysmal subarachnoid hemorrhage: analysis of nationwide database (Swiss SOS (Swiss Study on Aneurysmal Subarachnoid Hemorrhage)). Stroke 2018;49:333-340.
4. Pan P, Xu L, Zhang H, Liu Y, Lu X, Chen G, Tang H and Wu J. A Review of Hematoma Components Clearance Mechanism After Subarachnoid Hemorrhage. Front. Neurosci. 2020;14:685.doi: 10.3389/fnins.2020.00685
5. Hugelshofer M, Buzzi R, Schaer DJ, et al. Cerebrospinal fluid hemoglobin drives subarachnoid hemorrhage-related secondary brain injury. Nat Commun. 2021;12(1):3364.
6. Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Acta Neurochir Suppl. 2008;104:139-147.
7. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosurg. 2003;98(6):1167-1180.
8. Schallner N, Lieberum JL, Gallo D, et al. Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1. J Clin Invest. 2015;125(10):4109-4125.
9. Wang J, Doré S. Heme oxygenase-1 exacerbates early brain injury after intracerebral hemorrhage. Brain. 2007;130(Pt 6):1643-1652.
10. Saba ES, Lee YY, Kim M, et al. Roles of Heme Oxygenase-1 in Neuroinflammation and Brain Health. Int J Mol Sci. 2022;23(11):6217.
11. Thilak S, Brown P, Lawrence E, Gopal S, Mullhi R, Chacko C, Ahmed Z, Chelvarajah R, Pooni J, Veenith T. Delayed cerebral ischaemia after subarachnoid haemorrhage: pathophysiology, diagnosis and neurotherapeutic opportunities. Discover Medicine 2025;2:103.
12. Schmidt TP, Weiss M, Hoellig A, et al. Revisiting the timeline of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: toward a temporal risk profile. Neurocrit Care 2022;37:735-743.
13. Francoeur CL, Mayer SA. Cerebral vasospasm after subarachnoid hemorrhage. Critical Care Clinics 2016;32(1):1-16.
14. Fang YJ, Mei SH, Lu JN, Chen YK, Chai ZH, Dong X, Araujo C, Reis C, Zhang JM, Chen S. New risk score of the early period after spontaneous subarachnoid hemorrhage: For the prediction of delayed cerebral ischemia. CNS Neurosci Ther. 2019;25(10):1173-1181.
15. van der Steen WE, Leemans EL, van den Berg R, et al. Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: systematic review and meta-analysis. Neuroradiology 2019;61,247–256.
16. de Rooij NK, Rinkel GJE, Dankbaar JW, Frijns CJM. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44(1):43-54.
17. Xiao ZK, Wang B, Liu JH, et al. Risk factors for the development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. World Neurosurgery 2025;193:427-446.
18. Schirmer CM, Baker A, Bulsara KR, et al. Diagnostic cerebral angiography: a report of the SNIS Standards and Guidelines Committee, endorsed by ANZSNR and ESMINT. J Neurointerv Surg. 2026 Apr 30. doi:10.1136/jnis-2026-024980.
19. Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2023;54(7):e314-e370.
20. Lolli VE, Guenego A, Sadeghi N, Jodaitis L, Lubicz B, Taccone FS, Gouvea Bogossian E. CT perfusion imaging in aneurysmal subarachnoid hemorrhage. State of the art. Front Radiol. 2024;4:1445676.
21. Park JJ, Kim Y, Chai CL, Jeon JP. Application of Near-Infrared Spectroscopy for the detection of delayed cerebral ischemia in poor-grade subarachnoid hemorrhage. Neurocrit Care 2021;35(3):767-774.
22. Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Pickard JD, Menon DK. Monitoring cerebral blood flow and metabolism with microdialysis and tissue oxygenation. Acta Neurochir Suppl. 2012;114:123-129.
23. Stovell MG, Helmy A, Thelin EP, Jalloh I, Hutchinson PJ, Carpenter KLH. An overview of clinical cerebral microdialysis in acute brain injury. Front Neurol. 2023;14:1135061.
24. McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1128-1134.
25. Siman R, Giovannone N, Toraskar N, Frangos S, Stein SC, Levine JM, Kumar MA. Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PLoS One. 2011;6(12):e28938.
26. Akeret K, Buzzi RM, Saxenhofer M, et al. The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury. BMC Neurology 2022;22:267.
27. Macdonald RL, Weir B. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Rev Neurol. 2007;3:256-263.
28. Hänggi D, Etminan N, Aldrich F, Steiger HJ, Mayer SA, Diringer MN, Hoh BL, Mocco J, Faleck HJ, Macdonald RL; NEWTON Investigators. Randomized, open-label, phase 1/2a study to determine the maximum tolerated dose of intraventricular sustained release nimodipine for subarachnoid hemorrhage (NEWTON). Stroke. 2017;48(1):145-151.
29. Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. South Med J. 2009;102(2):150-153.
30. Castle-Kirszbaum M, Lai L, Maingard J, Asadi H, Danks RA, Goldschlager T, Chandra RV. Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review. Neurosurgical Review. 2021;44(6):3107-3124.
31. Amin-Hanjani S, Ogilvy CS, Barker FG 2nd, Dumont AS, Kassell NF, Dempsey RJ, Lawton MT, Haines SJ. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery. 2004;54(2):326-335; discussion 334-335.
32. Carrera E, Schmidt JM, Oddo M, et al. Cerebral autoregulation in subarachnoid hemorrhage. Front Neurol. 2021;12:688362..
33. Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 2016;20(1):277.
34. Daou BJ, Koduri S, Thompson BG, Chaudhary N, Pandey AS. Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage. CNS Neurosci Ther. 2019; 25: 1096-1112.
35. Nastasovic T, Lazic I, Ilic R, Milisavljevic F. Delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage- areas at risk. Neurosurg Rev. 2024;47(1):284.
36. Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, van Oostenbrugge RJ, Al-Shahi Salman R, Lavados PM, Rinkel GJ, van den Bergh WM; MASH-2 Study Group. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet 2012 Jul 7;380(9836):44-9.
37. Picetti E, Barbanera A, Bernucci C, Bertuccio A, Bilotta F, Boccardi EP, Cafiero T, Caricato A, Castioni CA, Cenzato M, Chieregato A, Citerio G, Gritti P, Lanterna L, Menozzi R, Munari M, Panni P, Rossi S, Stocchetti N, Sturiale C, Zoerle T, Zona G, Rasulo F, Robba C. Early management of patients with aneurysmal subarachnoid hemorrhage in a hospital with neurosurgical/neuroendovascular facilities: a consensus and clinical recommendations of the Italian Society of Anesthesia and Intensive Care (SIAARTI)-part 2. J Anesth Analg Crit Care 2022;2(1):21.
Downloads
Published
Data Availability Statement
Data sharing is not applicable, as no original research data were generated or analyzed.
Issue
Section
License
Copyright (c) 2026 Tijana Nastasovic (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work and grant the Macedonian Journal of Anaesthesia the right of first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work, provided that its initial publication in this journal is acknowledged.
